No Data
No Data
Lifecore Biomedical (NASDAQ:LFCR) Investors Are Sitting on a Loss of 33% If They Invested Five Years Ago
Express News | Lifecore Biomedical Inc - Credit Facility Term Extended to November 2027
Express News | Lifecore Biomedical Amends and Extends Revolving Credit Facility With BMO
Press Release: Lifecore Biomedical Amends and Extends Revolving Credit Facility With BMO
Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating, Announces Target Price $10
Barrington Remains a Hold on Lifecore Biomedical (LFCR)
No Data
No Data